Dr. Adam Cohen, MD
Claim this profileInova Schar Cancer Institute
Studies Glioblastoma
Studies Brain Tumor
11 reported clinical trials
22 drugs studied
Area of expertise
1Glioblastoma
IDH negative
MET positive
MET negative
2Brain Tumor
SMO positive
PTCH1 positive
H3 K27M positive
Affiliated Hospitals
Clinical Trials Adam Cohen, MD is currently running
NanO2
for Glioblastoma
This trial is testing a new treatment that delivers more oxygen to tumors. It aims to help patients with a specific type of brain cancer by making radiation therapy more effective. By increasing oxygen levels in the tumor, the treatment helps radiation work better at killing cancer cells.
Recruiting0 awards Phase 210 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Adam Cohen, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Adam Cohen, MD has experience with
- Nivolumab
- Ipilimumab
- Lomustine
- ONC201
- Aromatase Inhibitor
- CDK Inhibition
Breakdown of trials Adam Cohen, MD has run
Glioblastoma
Brain Tumor
Relapse
Benign Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Cohen, MD specialize in?
Adam Cohen, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is Adam Cohen, MD currently recruiting for clinical trials?
Yes, Adam Cohen, MD is currently recruiting for 6 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Adam Cohen, MD has studied deeply?
Yes, Adam Cohen, MD has studied treatments such as Nivolumab, Ipilimumab, Lomustine.
What is the best way to schedule an appointment with Adam Cohen, MD?
Apply for one of the trials that Adam Cohen, MD is conducting.
What is the office address of Adam Cohen, MD?
The office of Adam Cohen, MD is located at: Inova Schar Cancer Institute, Fairfax, Virginia 22031 United States. This is the address for their practice at the Inova Schar Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.